Episode cover
← Prof G Markets

Can a GLP-1 Pill Revive Novo Nordisk?

January 7, 2026·31m

Ed Elson speaks with Alex Heath, host of the ACCESS Podcast, about why Nvidia is dominating the news out of the CES conference. Then Jared Holz, Healthcare Equity Strategist at Mizuho, joins the show to discuss what Novo Nordisk’s new Wegovy pill means for the healthcare industry.